DrugPatentWatch Database Preview
NATROBA Drug Profile
Which patents cover Natroba, and when can generic versions of Natroba launch?
Natroba is a drug marketed by Parapro Llc and is included in one NDA. There are three patents protecting this drug.
This drug has forty-eight patent family members in thirty countries.
The generic ingredient in NATROBA is spinosad. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the spinosad profile page.
Summary for NATROBA
| International Patents: | 48 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 3 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for NATROBA |
| Drug Sales Revenues: | Drug sales revenues for NATROBA |
| DailyMed Link: | NATROBA at DailyMed |
Recent Clinical Trials for NATROBA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Accelovance | Phase 3 |
| ParaPRO LLC | Phase 3 |
| ParaPRO LLC | Phase 4 |
Pharmacology for NATROBA
| Drug Class | Pediculicide |
Synonyms for NATROBA
| Comfortis |
| EC 434-300-1 |
| NaturaLyte |
| Spinosad [USAN] |
| UNII-XPA88EAP6V |
| XDE 105 |
| XPA88EAP6V |
US Patents and Regulatory Information for NATROBA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parapro Llc | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Parapro Llc | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Parapro Llc | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NATROBA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Parapro Llc | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | Start Trial | Start Trial |
| Parapro Llc | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NATROBA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 003060 | Start Trial |
| Mexico | PA02004088 | Start Trial |
| Canada | 2382806 | Start Trial |
| Germany | 60210012 | Start Trial |
| Slovakia | 20062000 | Start Trial |
| Germany | 69931309 | Start Trial |
| Czech Republic | 20004865 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for NATROBA
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0375316 | SPC/GB02/028 | United Kingdom | Start Trial | PRODUCT NAME: SPINOSAD; REGISTERED: CH W 6020 20010313; UK 0714 20020227 |
| 0375316 | C350009 | Netherlands | Start Trial | PRODUCT NAME: SPINOSAD, DESGEWENST IN DE VORM VAN EEN ZOUT; NATL. REGISTRATION NO/DATE: 12363 N 20020913; FIRST REGISTRATION: SE 4511 20020204 |
| 0375316 | 06C0047 | France | Start Trial | PRODUCT NAME: SPINOSAD; REGISTRATION NO/DATE IN FRANCE: 2060098 DU 20060628; REGISTRATION NO/DATE AT EEC: 9275/B DU 20011023 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
